March 2026
1. BOISTEAU E, Landrieux A, Gnep K, Ahrweiller F, et al
   Efficacy of haemostatic radiotherapy for bleeding related to nonoperable advanced gastric cancer.
   Clin Res Hepatol Gastroenterol. 2026 Mar 10:102803.
   

   >> Share

   
   December 2025
2. LIU Z, Wang Y, Hong J, He F, et al
   Do serum biomarkers correlate to the risk of gastric lesions in patients with autoimmune gastritis?-A systematic review and meta-analysis.
   Clin Res Hepatol Gastroenterol. 2025;49:102722.
   

   >> Share

   
   November 2025
3. WANG F, Feng X, Sun J, Fan X, et al
   Impact of dynamic changes in multiple serum tumor markers during neoadjuvant therapy on clinical outcome in gastrointestinal cancer.
   Clin Res Hepatol Gastroenterol. 2025;49:102692.
   

   >> Share

   
   July 2025
4. GULIYEV M, Safarov S, Gunaltili M, Fidan MC, et al
   The impact of low HER2 expression on clinicopathological features and clinical outcomes in patients with metastatic gastric cancer.
   Clin Res Hepatol Gastroenterol. 2025;49:102646.
   

   >> Share

   
   April 2025
5. CHEN Y, Ji X, Zhao W, Lin J, et al
   A real-world study on the characteristics of autoimmune gastritis: A single-center retrospective cohort in China.
   Clin Res Hepatol Gastroenterol. 2025;49:102556.
   

   >> Share

   
   March 2025
6. SANGHVI G, R R, Kashyap A, Sabarivani A, et al
   Identifying the Function of Kinesin Superfamily Proteins in Gastric Cancer: Implications for Signal Transduction, Clinical Significance, and Potential Therapeutic Approaches.
   Clin Res Hepatol Gastroenterol. 2025 Mar 8:102571.
   

   >> Share

   
   November 2024
7. CAO X, Kang Y, Tai P, Zhang P, et al
   Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis.
   Clin Res Hepatol Gastroenterol. 2024;49:102510.
   

   >> Share

   
   October 2024
8. WU R, Yuan S, Wang Y, Nan Y, et al
   Efficacy and safety of ramucirumab in gastric or gastroesophageal cancer: A systematic review and meta-analysis.
   Clin Res Hepatol Gastroenterol. 2024;48:102466.
   

   >> Share

   
   May 2024
9. SHI H, Kong S
   A comprehensive evaluation of serum circCSPP1 as a novel diagnostic and prognostic biomarker for gastric cancer.
   Clin Res Hepatol Gastroenterol. 2024;48:102367.
   

   >> Share

   
   
10. WU N, Ding Y, Huang WF
    A rare case of gastroduodenal glomus tumor.
    Clin Res Hepatol Gastroenterol. 2024;48:102333.
    

    >> Share

    
    April 2024
11. HAN DG, Wang K, Liu W
    Gastric adenocarcinoma of fundic gland (chief cell predominant) type.
    Clin Res Hepatol Gastroenterol. 2024;48:102306.
    

    >> Share

    
    January 2024
12. HAN X, Jia X, Sheng C, Li M, et al
    A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer.
    Clin Res Hepatol Gastroenterol. 2024 Jan 20:102287.
    

    >> Share

    
    
13. XU Y, Song Y, Zhang B, Yang Y, et al
    Clinicopathological characteristics of crawling-type gastric adenocarcinoma.
    Clin Res Hepatol Gastroenterol. 2024;48:102262.
    

    >> Share

    
    
14. MARTIN A, Jauvain M, Bergsten E, Demontant V, et al
    Gastric microbiota in patients with gastric MALT lymphoma according to Helicobacter pylori infection.
    Clin Res Hepatol Gastroenterol. 2024;48:102247.
    

    >> Share

    
    November 2023
15. DEPOTTE L, Palle J, Rasola C, Broudin C, et al
    New developments and standard of care in the management of advanced gastric cancer.
    Clin Res Hepatol Gastroenterol. 2023 Nov 10:102245.
    

    >> Share

    
    August 2023
16. DU C, He Z, Li L, Ning B, et al
    Endoscopic resection for the treatment of non-gastric gastrointestinal stromal tumors: A retrospective study from a large tertiary hospital in China.
    Clin Res Hepatol Gastroenterol. 2023;47:102152.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share